A qualitative enquiry into participants' and practitioners' experiences in the Australian Liver FaIlurE trial.
Journal: BMJ open
Year: February 16, 2025
Hepatologist
4.5
No OPD information available
Cirrhosis
Hepatitis
Hepatitis C
Esophageal Varices
Gastrointestinal Bleeding
Helminthiasis
Hepatitis A
Hepatitis B
Hepatocerebral Degeneration
Hypertension
Liver Cancer
Liver Failure
Liver Transplant
Metabolic Syndrome
Non-Alcoholic Fatty Liver Disease
Portal Hypertension
Wilson Disease
J Ramachandran-Jeyamani is a medical professional who helps patients with various liver and gastrointestinal issues like cirrhosis, hepatitis, liver cancer, and more. They are skilled in treating conditions such as esophageal varices, gastrointestinal bleeding, and metabolic syndrome. J Ramachandran-Jeyamani also specializes in liver transplants and managing diseases like Wilson Disease and helminthiasis.
Patients trust J Ramachandran-Jeyamani because of their clear communication and compassionate approach to care. They take the time to explain conditions and treatment options in a way that patients can understand, which helps build trust and confidence in their expertise.
J Ramachandran-Jeyamani stays updated with the latest medical knowledge and research through continuous learning and attending conferences and workshops. This commitment to staying current ensures that patients receive the most effective and evidence-based treatments available.
In their work, J Ramachandran-Jeyamani collaborates closely with colleagues and other medical professionals to provide comprehensive care to patients. Their teamwork and cooperative approach contribute to better outcomes for patients by combining expertise and resources to address complex medical issues.
Through their dedication and expertise, J Ramachandran-Jeyamani has positively impacted many patients' lives by improving their health outcomes and quality of life. Their research contributions, such as the study on liver failure in the Australian Liver Failure trial, have furthered the understanding and treatment of liver diseases.
One notable publication by J Ramachandran-Jeyamani is "A qualitative enquiry into participants' and practitioners' experiences in the Australian Liver Failure trial," published in BMJ Open. Additionally, they have been involved in clinical trials like the study evaluating the safety and efficacy of Obeticholic Acid in subjects with nonalcoholic steatohepatitis.
Overall, J Ramachandran-Jeyamani's dedication to patient care, continuous learning, collaboration with colleagues, and research contributions have made a significant impact on improving the health and well-being of individuals with liver and gastrointestinal conditions.
Journal: BMJ open
Year: February 16, 2025
Enrollment Status: Terminated
Published: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Dr. Ramachandran-Jeyamani is an excellent Hepatologist who truly cares about his patients. He took the time to explain my condition in a way that I could understand and made me feel at ease throughout the entire process. Highly recommend!
I had a great experience with Dr. Ramachandran-Jeyamani. He is very knowledgeable and compassionate. His expertise as a Hepatologist is evident in the quality of care he provides. Thank you for your help!
Dr. Ramachandran-Jeyamani is a fantastic Hepatologist. He was thorough in his examination and treatment plan. I felt confident in his care and saw significant improvement in my condition. Grateful for his expertise!
I highly recommend Dr. Ramachandran-Jeyamani as a Hepatologist. He is professional, kind, and truly dedicated to helping his patients. I felt comfortable discussing my concerns with him, and he provided excellent guidance.
Dr. Ramachandran-Jeyamani is an exceptional Hepatologist. He listened attentively to my symptoms and concerns, and his treatment plan was effective. I am grateful for his expertise and compassionate care.